CBD has shown promise as a treatment for psychosis in small studies and case reports. A large, international trial launching ...

For people with non-modifiable risk factors, lifestyle changes may not be enough to lower blood pressure enough to stop blood pressure medications. However, treating conditions that contribute to high ...

One of those is that a popular drug for severe headache sufferers could cut women’s risk of stroke in half, new research says. Propranolol, a beta blocker also sometimes used in the treatment of high ...

Type 2 diabetes is a form of diabetes characterized by high blood sugar (glucose ... However, typically, type 2 diabetes is treated with medication plus lifestyle modifications. The following article ...

Before you start this drug, make sure your doctor knows if you're pregnant, nursing, or thinking of starting a family. Aliskiren can pose a serious risk to your baby's health. Your doctor may also ...

Share on Pinterest New research confirms that keeping blood pressure in check could help lower cognitive decline risk as we age ... on treatment involving medication rather than any lifestyle ...

Jan 28 (Reuters) - The U.S. FDA has approved Novo Nordisk's (NOVOb.CO), opens new tab Ozempic for reducing the risk of kidney failure ... Novo's blockbuster diabetes drug Ozempic belongs to ...

Standardizing an assessment process currently used by doctors during care discussions with veterans at risk for suicide in ... an overdose-reversing drug. In addition, researchers found that ...

A recent study showed different medications and drug classes could inadvertently affect a person’s risk of dementia ... the different drug classes and form connections in the hopes of making ...

It is common for an older person to acquire an ever-growing number of medications as ... will help uncover any risk factors which may lead to further risk assessment through stress testing ...

“These findings suggest that medically recommended cannabis is not associated with reduced addiction risk compared with nonmedical use,” the research team led by Dr. Nora Volkow, director of the ...